| Dr Katherine Nina Riedy-graves, MD | |
|
2546 Balltown Rd Ste 300, Schenectady, NY 12309-1079 | |
| (518) 377-8184 | |
| Not Available |
| Full Name | Dr Katherine Nina Riedy-graves |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 2546 Balltown Rd Ste 300, Schenectady, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790164150 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 289423 (New York) | Primary |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Affygility Solutions, LLC, a global leader in providing environmental, health and safety solutions to the life sciences industry, announced today the launch of its newest version of its environmental, health, and safety software, Affytrac, with multi-corrective action functionality. Users can now create an infinite amount of corrective actions for a single parent issue.
Advaxis, Inc., the live, attenuated Listeria monocytogenes biotechnology company, has dosed the first patient in its US Food and Drug Administration -approved, phase II clinical trial in cervical intraepithelial neoplasia, commonly known as cervical dysplasia.
Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.
Genoptix, announced today that it has entered into a definitive merger agreement to be acquired by Novartis. Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at USD$25.00 per share.
Conmed Healthcare Management, Inc, a leading full service provider of correctional facility healthcare services to county and municipal detention centers, today announced that it has signed a full-service agreement with the City of Virginia Beach, Virginia, for an initial three-year term with options for two one-year extensions at the City's option.
› Verified 5 days ago
| Entity Name | St. Peter's Health Partners Medical Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750626834 PECOS PAC ID: 6103061189 Enrollment ID: O20130321000567 |
News Archive
Affygility Solutions, LLC, a global leader in providing environmental, health and safety solutions to the life sciences industry, announced today the launch of its newest version of its environmental, health, and safety software, Affytrac, with multi-corrective action functionality. Users can now create an infinite amount of corrective actions for a single parent issue.
Advaxis, Inc., the live, attenuated Listeria monocytogenes biotechnology company, has dosed the first patient in its US Food and Drug Administration -approved, phase II clinical trial in cervical intraepithelial neoplasia, commonly known as cervical dysplasia.
Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.
Genoptix, announced today that it has entered into a definitive merger agreement to be acquired by Novartis. Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at USD$25.00 per share.
Conmed Healthcare Management, Inc, a leading full service provider of correctional facility healthcare services to county and municipal detention centers, today announced that it has signed a full-service agreement with the City of Virginia Beach, Virginia, for an initial three-year term with options for two one-year extensions at the City's option.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine Nina Riedy-graves, MD Po Box 14890, Albany, NY 12212-4890 Ph: () - | Dr Katherine Nina Riedy-graves, MD 2546 Balltown Rd Ste 300, Schenectady, NY 12309-1079 Ph: (518) 377-8184 |
News Archive
Affygility Solutions, LLC, a global leader in providing environmental, health and safety solutions to the life sciences industry, announced today the launch of its newest version of its environmental, health, and safety software, Affytrac, with multi-corrective action functionality. Users can now create an infinite amount of corrective actions for a single parent issue.
Advaxis, Inc., the live, attenuated Listeria monocytogenes biotechnology company, has dosed the first patient in its US Food and Drug Administration -approved, phase II clinical trial in cervical intraepithelial neoplasia, commonly known as cervical dysplasia.
Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy product designed to deliver the neurotrophic factor neurturin, for Parkinson's disease.
Genoptix, announced today that it has entered into a definitive merger agreement to be acquired by Novartis. Under the terms of the merger agreement, Novartis will commence an all cash tender offer for all outstanding shares of common stock of Genoptix at USD$25.00 per share.
Conmed Healthcare Management, Inc, a leading full service provider of correctional facility healthcare services to county and municipal detention centers, today announced that it has signed a full-service agreement with the City of Virginia Beach, Virginia, for an initial three-year term with options for two one-year extensions at the City's option.
› Verified 5 days ago
Dr. Abul K Azad, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2125 River Road, Suite 203, Schenectady, NY 12309 Phone: 518-831-8530 Fax: 518-831-8545 | |
Dr. Saddam Saleh Abisse, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2546 Balltown Rd Ste 300, Schenectady, NY 12309 Phone: 518-377-8184 Fax: 183-705-1435 | |
David Charles Armenia, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2546 Balltown Rd, Suite 203, Schenectady, NY 12309 Phone: 518-377-8198 Fax: 518-377-0620 | |
Dr. Dinesh Kommareddy, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1101 Nott St, Schenectady, NY 12308 Phone: 518-243-4000 | |
Dr. Richard Bruce Toll, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1201 Nott St, Suite 102, Schenectady, NY 12308 Phone: 518-382-7500 Fax: 518-382-7572 | |
Ayman Habib Morgan, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2125 River Rd, Ste 303, Schenectady, NY 12309 Phone: 518-831-2500 Fax: 518-831-2510 | |
Dr. Anita K Burock Stotts, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 Anthony Way, Schenectady, NY 12303 Phone: 518-355-2060 |